GlassScriptPhysician profile
Brook A Dejene
NPI 1013918416
$8,665.62
in general payments reported to CMS, 2019-2025
11 companies · $1,738 in 2025
The $1,738 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,711 · 2020: $413 · 2021: $305 · 2022: $118 · 2023: $2,717 · 2024: $1,663 · 2025: $1,738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,030 · Food and Beverage: $2,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,030.34 |
| Food and Beverage | $2,087.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,845.29 | 2019-2025 | Mitraclip, Navitor, Epic |
| Medtronic, INC. | $1,338.14 | 2023 | Apollotm |
| Artivion, INC. | $891.55 | 2025 | Amds-Ascyrus Medical |
| Medtronic Vascular, INC. | $883.59 | 2019-2020 | |
| Edwards Lifesciences Corporation | $719.03 | 2021-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Abiomed | $563.13 | 2023-2025 | Impella |
| Boston Scientific Corporation | $201.75 | 2019-2022 | |
| Atricure, INC. | $123.55 | 2021-2023 | |
| Baxter Healthcare | $67.54 | 2021 | |
| Siemens Medical Solutions USA, INC. | $19.03 | 2025 | Naeotom Alpha |
| Novo Nordisk INC | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brook Dejene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.